Estradiol regulates Tumor Necrosis Factor-α expression and secretion in Estrogen Receptor positive breast cancer cells

Molecular and Cellular Endocrinology

Volumn 394, Issue 1-2, 2014, Pages 21-28

  To, Sarah Q ^a,b   Cheung, Vanessa ^a,b   Lazarus, Kyren A ^a,b,c   Knower, Kevin C ^a,b   Clyne, Colin D ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Breast cancer; ER ; Estradiol; TNF

Indexed keywords

AFIMOXIFENE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; ANTIESTROGEN; ESTROGEN RECEPTOR ALPHA; PROTEIN BINDING; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG EFFECT; EPITHELIUM CELL; FEEDBACK SYSTEM; GENETIC ASSOCIATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE BINDING; HORMONE RELEASE; HUMAN; HUMAN CELL; META ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; AGONISTS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; TAMOXIFEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904498189     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.06.020     Document Type: Article

References (42)

1. Buzdar A., Howell A., Cuzick J., Wale C., Distler W., Hoctin-Boes G., Houghton J., Locker G.Y., Nabholtz J.M. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol. 2006, 7(8):633-643.
2. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 1975, 72(9):3666-3670.
3. Chand A.L., Wijayakumara D.D., Knower K.C., Herridge K.A., Howard T.L., Lazarus K.A., Clyne C.D. The orphan nuclear receptor LRH-1 and ERalpha activate GREB1 expression to induce breast cancer cell proliferation. PLoS ONE 2012, 7(2):e31593.
4. Che Q., Liu B.Y., Liao Y., Zhang H.J., Yang T.T., He Y.Y., Xia Y.H., Lu W., He X.Y., Chen Z., Wang F.Y., Wan X.P. Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17β-estradiol biosynthesis in endometrial carcinoma microenvironment. Int. J. Cancer 2014, 135(2):282-294. 10.1002/ijc.28679.
5. De M., Sanford T.R., Wood G.W. Interleukin-1, interleukin-6, and tumor necrosis factor alpha are produced in the mouse uterus during the estrous cycle and are induced by estrogen and progesterone. Dev. Biol. 1992, 151(1):297-305.
6. Deb S., Amin S., Imir A.G., Yilmaz M.B., Suzuki T., Sasano H., Bulun S.E. Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts. J. Clin. Endocrinol. Metab. 2004, 89(8):4018-4024.
7. Duncan L.J., Reed M.J. The role and proposed mechanism by which oestradiol 17 beta-hydroxysteroid dehydrogenase regulates breast tumour oestrogen concentrations. J. Steroid Biochem. Mol. Biol. 1995, 55(5-6):565-572.
8. Duncan L.J., Coldham N.G., Reed M.J. The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 1994, 49(1):63-68.
9. Eichbaum C., Meyer A.S., Wang N., Bischofs E., Steinborn A., Bruckner T., Brodt P., Sohn C., Eichbaum M.H. Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Res. 2011, 31(10):3219-3227.
10. Fisher B., Costantino J.P., Redmond C.K., Fisher E.R., Wickerham D.L., Cronin W.M. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J. Natl. Cancer Inst. 1994, 86(7):527-537.
11. Hamaguchi T., Wakabayashi H., Matsumine A., Sudo A., Uchida A. TNF inhibitor suppresses bone metastasis in a breast cancer cell line. Biochem. Biophys. Res. Commun. 2011, 407(3):525-530.
12. Haranaka K., Satomi N. Cytotoxic activity of tumor necrosis factor (TNF) on human cancer cells in vitro. Jpn. J. Exp. Med. 1981, 51(3):191-194.
13. Jeoung D.I., Tang B., Sonenberg M. Effects of tumor necrosis factor-alpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J. Biol. Chem. 1995, 270(31):18367-18373.
14. Jordan V.C. Effects of tamoxifen in relation to breast cancer. Br. Med. J. 1977, 1(6075):1534-1535.
15. Kelly P.M., Davison R.S., Bliss E., McGee J.O. Macrophages in human breast disease: a quantitative immunohistochemical study. Br. J. Cancer 1988, 57(2):174-177.
16. Kornbluth R.S., Edgington T.S. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J. Immunol. 1986, 137(8):2585-2591.
17. Lee S.H., Nam H.S. TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells. Mol. Cells 2008, 26(3):285-290.
18. Leek R.D., Landers R., Fox S.B., Ng F., Harris A.L., Lewis C.E. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br. J. Cancer 1998, 77(12):2246-2251.
19. Li J., Zha X.M., Wang R., Li X.D., Xu B., Xu Y.J., Yin Y.M. Regulation of CD44 expression by tumor necrosis factor-alpha and its potential role in breast cancer cell migration. Biomed. Pharmacother. 2012, 66(2):144-150.
20. Lyman S.D., Jordan V.C. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus. Biochem. Pharmacol. 1985, 34(15):2795-2806.
21. Macdiarmid F., Wang D., Duncan L.J., Purohit A., Ghilchick M.W., Reed M.J. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol. Cell. Endocrinol. 1994, 106(1-2):17-21.
22. Manning D.L., Archibald L.H., Ow K.T. Cloning of estrogen-responsive messenger RNAs in the T-47D human breast cancer cell line. Cancer Res. 1990, 50(13):4098-4104.
23. McCloskey E.V., Hannon R.A., Lakner G., Fraser W.D., Clack G., Miyamoto A., Finkelman R.D., Eastell R. Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women. Eur. J. Cancer 2007, 43(17):2523-2531.
24. Meng L., Zhou J., Sasano H., Suzuki T., Zeitoun K.M., Bulun S.E. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Cancer Res. 2001, 61(5):2250-2255.
25. Miki Y., Suzuki T., Nagasaki S., Hata S., Akahira J., Sasano H. Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J. Steroid Biochem. Mol. Biol. 2009, 113(3-5):281-289.
26. Mochizuki Y., Nakanishi H., Kodera Y., Ito S., Yamamura Y., Kato T., Hibi K., Akiyama S., Nakao A., Tatematsu M. TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin. Exp. Metastasis 2004, 21(1):39-47.
27. Neels J.G., Pandey M., Hotamisligil G.S., Samad F. Autoamplification of tumor necrosis factor-alpha: a potential mechanism for the maintenance of elevated tumor necrosis factor-alpha in male but not female obese mice. Am. J. Pathol. 2006, 168(2):435-444.
28. Newman S.P., Purohit A., Ghilchik M.W., Potter B.V., Reed M.J. Regulation of steroid sulphatase expression and activity in breast cancer. J. Steroid Biochem. Mol. Biol. 2000, 75(4-5):259-264.
29. Pileczki V., Braicu C., Gherman C.D., Berindan-Neagoe I. TNF-alpha gene knockout in triple negative breast cancer cell line induces apoptosis. Int. J. Mol. Sci. 2012, 14(1):411-420.
30. Purohit A., Wang D.Y., Ghilchik M.W., Reed M.J. Regulation of aromatase and sulphatase in breast tumour cells. J. Endocrinol. 1996, 150(suppl.):S65-S71.
31. Sasano H., Ozaki M. Aromatase expression and its localization in human breast cancer. J. Steroid Biochem. Mol. Biol. 1997, 61(3-6):293-298.
32. Scott K.A., Moore R.J., Arnott C.H., East N., Thompson R.G., Scallon B.J., Shealy D.J., Balkwill F.R. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. 2003, 2(5):445-451.
33. To S.Q., Knower K.C., Clyne C.D. Origins and actions of tumor necrosis factor alpha in postmenopausal breast cancer. J. Interferon Cytokine Res. 2013, 33(7):335-345.
34. To S.Q., Knower K.C., Clyne C.D. NFkappaB and MAPK signalling pathways mediate TNFalpha-induced early growth response gene transcription leading to aromatase expression. Biochem. Biophys. Res. Commun. 2013, 433(1):96-101.
35. To S.Q., Simpson E.R., Knower K.C., Clyne C.D. Involvement of early growth response factors in TNFalpha-induced aromatase expression in breast adipose. Breast Cancer Res. Treat. 2013, 138(1):193-203.
36. Wang H.J., Wu Z.Y., Fan P., Bian J.M. The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells. Zhonghua Wai Ke Za Zhi 2005, 43(15):1014-1016.
37. Warren M.A., Shoemaker S.F., Shealy D.J., Bshar W., Ip M.M. Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice. Mol. Cancer Ther. 2009, 8(9):2655-2663.
38. Yin Y., Chen X., Shu Y. Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells. Biomed. Pharmacother. 2009, 63(6):421-428.
39. Yu M., Zhou X., Niu L., Lin G., Huang J., Zhou W., Gan H., Wang J., Jiang X., Yin B., Li Z. Targeting transmembrane TNF-alpha suppresses breast cancer growth. Cancer Res. 2013, 73(13):4061-4074.
40. Zaldivar V., Magri M.L., Zarate S., Jaita G., Eijo G., Radl D., Ferraris J., Pisera D., Seilicovich A. Estradiol increases the expression of TNF-alpha and TNF receptor 1 in lactotropes. Neuroendocrinology 2011, 93(2):106-113.
41. Zhang B., Berger J., Hu E., Szalkowski D., White-Carrington S., Spiegelman B.M., Moller D.E. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol. Endocrinol. 1996, 10(11):1457-1466.
42. Zhao Y., Agarwal V.R., Mendelson C.R., Simpson E.R. Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J. Steroid Biochem. Mol. Biol. 1997, 61(3-6):203-210.